» Articles » PMID: 20869972

Speedball Induced Changes in Electrically Stimulated Dopamine Overflow in Rat Nucleus Accumbens

Overview
Specialties Neurology
Pharmacology
Date 2010 Sep 28
PMID 20869972
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cocaine/heroin combinations (speedball) induce a synergistic elevation in extracellular dopamine concentrations ([DA](e)) in the nucleus accumbens (NAc) that can explain the increased abuse liability of speedball. To further delineate the mechanism of this neurochemical synergism, in vivo fast-scan cyclic voltammetry (FSCV) was used to compare NAc DA release and reuptake kinetic parameters following acute administration of cocaine, heroin and speedball in drug-naïve rats. These parameters were extracted from accumbal DA overflow induced by electrical stimulation of the ventral tegmental area. Evoked DA efflux was increased following both cocaine and speedball delivery, whereas heroin did not significantly change evoked DA release from baseline. DA efflux was significantly greater following cocaine compared to speedball. However, DA transporter (DAT) apparent affinity (K(m)) values were similarly elevated following cocaine and speedball administration, but unaffected by heroin. Neither drug induced substantial changes in the maximal reuptake rate (V(max)). These data, combined with published microdialysis and electrophysiological results, indicate that the combination of cocaine-induced competitive inhibition of DAT and the increase in the DA release elicited by heroin is responsible for the synergistic increase in ([DA](e)) induced by speedball.

Citing Articles

Negative allosteric modulation of CB cannabinoid receptor signaling suppresses opioid-mediated reward.

Iyer V, Rangel-Barajas C, Woodward T, Kulkarni A, Cantwell L, Crystal J Pharmacol Res. 2022; 185:106474.

PMID: 36179954 PMC: 9948526. DOI: 10.1016/j.phrs.2022.106474.


Opposite environmental gating of the experienced utility ('liking') and decision utility ('wanting') of heroin versus cocaine in animals and humans: implications for computational neuroscience.

Badiani A, Caprioli D, De Pirro S Psychopharmacology (Berl). 2019; 236(8):2451-2471.

PMID: 31289884 PMC: 6695361. DOI: 10.1007/s00213-019-05318-9.


Effects of ( R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell.

Keighron J, Quarterman J, Cao J, DeMarco E, Coggiano M, Gleaves A ACS Chem Neurosci. 2019; 10(4):2012-2021.

PMID: 30645944 PMC: 8294083. DOI: 10.1021/acschemneuro.8b00340.


Optogenetically-induced tonic dopamine release from VTA-nucleus accumbens projections inhibits reward consummatory behaviors.

Mikhailova M, Bass C, Grinevich V, Chappell A, Deal A, Bonin K Neuroscience. 2016; 333:54-64.

PMID: 27421228 PMC: 4992643. DOI: 10.1016/j.neuroscience.2016.07.006.


Targeted genetic manipulations of neuronal subtypes using promoter-specific combinatorial AAVs in wild-type animals.

Gompf H, Budygin E, Fuller P, Bass C Front Behav Neurosci. 2015; 9:152.

PMID: 26190981 PMC: 4488755. DOI: 10.3389/fnbeh.2015.00152.


References
1.
Hemby S, Co C, Dworkin S, Smith J . Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats. J Pharmacol Exp Ther. 1998; 288(1):274-80. View

2.
Cass W, Gerhardt G . Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett. 1994; 176(2):259-63. DOI: 10.1016/0304-3940(94)90096-5. View

3.
Wightman R, Zimmerman J . Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res Brain Res Rev. 1990; 15(2):135-44. DOI: 10.1016/0165-0173(90)90015-g. View

4.
Wu Q, Reith M, Kuhar M, Carroll F, Garris P . Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J Neurosci. 2001; 21(16):6338-47. PMC: 6763153. View

5.
Hoffman D, Donovan H . D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia. Psychopharmacology (Berl). 1994; 115(4):447-53. DOI: 10.1007/BF02245567. View